Mdxhealth SA MDXH
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $107.88M, +19.8% YoY · Filed Apr 3, 2026
Mdxhealth SA (MDXH) files with the SEC under industry code 8071, Services-Medical Laboratories. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $107.9 million and a net loss of $33.5 million. Free cash flow was -$3.3 million. As of Dec 31, 2025 it held $29.0 million in cash and investments and $86.6 million in total debt.
Revenue
$107.88M
+19.8% vs prior year
Net income
$-33.52M
+12.0% vs prior year
Operating cash flow
$-2.19M
+88.2% vs prior year
Free cash flow
$-3.35M
+83.0% vs prior year
EPS
$-0.67
+42.2% vs prior year
Dividend per share
None
Shares outstanding
51.36M
+3.8% vs prior year
Net cash
$-57.57M
FY 2025
Operating margin
-13.4%
FY 2025
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- MDXH (Nasdaq)
- Incorporated in
- Belgium
- Headquarters
- Herstal, Belgium
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1872529
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $107.9M | $90.0M | $70.2M | $37.1M | $22.2M |
| Operating income | -$14.4M | -$24.7M | -$27.3M | -$37.9M | -$26.8M |
| Net income | -$33.5M | -$38.1M | -$43.1M | -$44.0M | -$29.0M |
| Diluted EPS | -$0.67 | -$1.16 | -$1.66 | -$2.78 | $2.38 |
| Operating cash flow | -$2.2M | -$18.5M | -$21.5M | -$34.1M | -$22.5M |
| Free cash flow | -$3.3M | -$19.7M | -$24.2M | -$36.9M | -$23.4M |
| Total assets | $148.0M | $157.3M | $129.1M | $119.1M | $75.1M |
| Total liabilities | $160.0M | $142.5M | $121.9M | $109.8M | $28.2M |
| Stockholders' equity | -$12.1M | $14.8M | $7.2M | $9.3M | $46.9M |
| Cash and investments | $29.0M | $46.8M | $22.4M | $15.5M | $58.5M |
| Total debt | $86.6M | $60.1M | $40.6M | $4.9M | $7.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 30, 2026 | Oct 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 16, 2026 | Oct 16, 2026 |
| 6-K | Current report (foreign issuer) | Sep 3, 2026 | Sep 3, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
| 6-K | Current report (foreign issuer) | Jul 24, 2026 | Jul 24, 2026 |
All 183 Mdxhealth SA SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.